Skip to main content

Table 1 Characteristics of patients and controls

From: Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein’s anomaly

  Ebstein’s anomaly(N = 44) Healthy Subjects(N = 44) P value
Age, yrs 34.0 ± 16.2 33.3 ± 16.1 0.923
10 ≤ age ≤ 18, yrs 7(15.9) 7 (15.9) 1.000
Male (n, %) 18(40.9) 18 (40.9) 1.000
BSA, m2 1.5 ± 0.2 1.6 ± 0.2 0.468
BMI, kg/m2 21.8 ± 4.8 21.7 ± 3.5 0.932
Heart rate, bpm 83.3 ± 12.7 73.6 ± 11.6 < 0.001
SO2 at rest, % 96.6 ± 2.6 99.0 ± 1.0 < 0.001
Hematocrit, % 42.5 ± 4.9 44.1 ± 5.2 0.071
ASD/PFO (n, %) 29 (65.9) 0
W-P-W (n, %) 6 (13.6) 0
Tricuspid regurgitation severity (n, %)   
 Moderate 12 (27.3) 0
 Severe 32 (72.7) 0
Carpentier’s classification
 Type A 18 (40.9)
 Type B 17 (38.6)
 Type C 8 (18.2)
 Type D 1 (2.3)
NYHA functional classification (n, %)
 I 10 (22.7)
 II 29 (65.9)
 III 5 (11.4)
  1. Abbreviations: BSA body surface area; BMI body mass index; ASD atrial septal defect; PFO patent foramen ovale; W-P-W Wolff-Parkinson-White; NYHA New York Heart Association